SELADELPAR (Livdeli®)

Clinical Indication

for previously treated primary biliary cholangitis

Comments

In line with NICE TA1171

Funding from 22nd September 2026

Date of classification

September 2026

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.